These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
548 related articles for article (PubMed ID: 30027649)
1. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. Khorana AA; Noble S; Lee AYY; Soff G; Meyer G; O'Connell C; Carrier M J Thromb Haemost; 2018 Sep; 16(9):1891-1894. PubMed ID: 30027649 [No Abstract] [Full Text] [Related]
4. Direct oral anticoagulants: An update. Franco Moreno AI; Martín Díaz RM; García Navarro MJ Med Clin (Barc); 2018 Sep; 151(5):198-206. PubMed ID: 29295790 [TBL] [Abstract][Full Text] [Related]
5. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. Robertson L; Kesteven P; McCaslin JE Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010957. PubMed ID: 26636644 [TBL] [Abstract][Full Text] [Related]
6. [What role for the direct oral anticoagulants in oncology?]. Lebellec L; Kouakam C; Bertrand N; Penel N Bull Cancer; 2018; 105(7-8):631-633. PubMed ID: 29960639 [No Abstract] [Full Text] [Related]
7. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy. Finks SW; Trujillo TC; Dobesh PP Ann Pharmacother; 2016 Jun; 50(6):486-501. PubMed ID: 26917821 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulants: What is new and what is the standard? Lesko LJ Clin Pharmacol Ther; 2016 Aug; 100(2):126-8. PubMed ID: 27197625 [TBL] [Abstract][Full Text] [Related]
10. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? Alamneh EA; Chalmers L; Bereznicki LR Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063 [TBL] [Abstract][Full Text] [Related]
11. Using new oral anticoagulants in patients undergoing major orthopedic surgery. Bass AR Curr Rheumatol Rep; 2015 Apr; 17(4):25. PubMed ID: 25854486 [TBL] [Abstract][Full Text] [Related]
12. Target-specific oral anticoagulants and the hospitalist. Deitelzweig S; Amin A Hosp Pract (1995); 2015; 43(1):1-12. PubMed ID: 25559350 [TBL] [Abstract][Full Text] [Related]
14. The Role of New Oral Anticoagulants (NOACs) in Cancer Patients. Ravikumar R; Lim CS; Davies AH Adv Exp Med Biol; 2017; 906():137-148. PubMed ID: 27620312 [TBL] [Abstract][Full Text] [Related]
15. The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH. Wang TF; Zwicker JI; Ay C; Pabinger I; Falanga A; Antic D; Noble S; Khorana AA; Carrier M; Meyer G J Thromb Haemost; 2019 Oct; 17(10):1772-1778. PubMed ID: 31353841 [No Abstract] [Full Text] [Related]
16. The new oral anticoagulants: Reasonable alternatives to warfarin. Roca B; Roca M Cleve Clin J Med; 2015 Dec; 82(12):847-54. PubMed ID: 26651894 [TBL] [Abstract][Full Text] [Related]
17. Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study. van Es N; Di Nisio M; Bleker SM; Segers A; Mercuri MF; Schwocho L; Kakkar A; Weitz JI; Beyer-Westendorf J; Boda Z; Carrier M; Chlumsky J; Décousus H; Garcia D; Gibbs H; Kamphuisen PW; Monreal M; Ockelford P; Pabinger I; Verhamme P; Grosso MA; Büller HR; Raskob GE Thromb Haemost; 2015 Nov; 114(6):1268-76. PubMed ID: 26271200 [TBL] [Abstract][Full Text] [Related]
18. Target-specific Oral Anticoagulants in the Emergency Department. Peacock WF; Levy PD; Gonzalez MG; Than M J Emerg Med; 2016 Feb; 50(2):246-57. PubMed ID: 26614713 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830 [TBL] [Abstract][Full Text] [Related]
20. [NOAC in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease]. Gottsäter A Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]